BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17136289)

  • 1. Treatment of gastroesophageal reflux disease.
    Guimarães EV; Marguet C; Camargos PA
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S133-45. PubMed ID: 17136289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.
    Tolia V; Ferry G; Gunasekaran T; Huang B; Keith R; Book L
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S308-18. PubMed ID: 12607791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole: in the management of gastroesophageal reflux disease in children.
    Scott LJ
    Paediatr Drugs; 2003; 5(1):57-61; discussion 62. PubMed ID: 12513106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux disease.
    Kahrilas PJ
    JAMA; 1996 Sep; 276(12):983-8. PubMed ID: 8805734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of gastroesophageal reflux disease.
    Ramakrishnan A; Katz PO
    Curr Gastroenterol Rep; 2002 Jun; 4(3):218-24. PubMed ID: 12010622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.
    Springer M; Atkinson S; North J; Raanan M
    Paediatr Drugs; 2008; 10(4):255-63. PubMed ID: 18590344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.
    Tolia V; Fitzgerald J; Hassall E; Huang B; Pilmer B; Kane R
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S300-7. PubMed ID: 12607790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.
    Tighe MP; Afzal NA; Bevan A; Beattie RM
    Paediatr Drugs; 2009; 11(3):185-202. PubMed ID: 19445547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
    Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
    J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
    Franco MT; Salvia G; Terrin G; Spadaro R; De Rosa I; Iula VD; Cucchiara S
    Dig Liver Dis; 2000 Nov; 32(8):660-6. PubMed ID: 11142573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexlansoprazole for the treatment of esophagitis and GERD.
    Davies SL
    Drugs Today (Barc); 2010 Feb; 46(2):75-80. PubMed ID: 20393635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
    Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
    Heyman MB; Zhang W; Huang B; Chiu YL; Amer F; Winter HS
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):35-40. PubMed ID: 17204950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination drug therapy for gastroesophageal reflux disease.
    Cross LB; Justice LN
    Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.